JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on April 12, 2002
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
277/16/13488    most recent
M107922200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dorsam, G. P.
Right arrow Articles by Goetzl, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dorsam, G. P.
Right arrow Articles by Goetzl, E. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print January 25, 2002
J. Biol. Chem, 10.1074/jbc.M107922200
Submitted on August 17, 2001
Revised on January 7, 2002
Accepted on January 25, 2002

Vasoactive intestinal peptide receptor - 1 (VPAC-1) is a novel gene target of the Hemolymphopoietic transcription factor ikaros

Glenn P. Dorsam and Edward J. Goetzl

Medicine, Immunology and Allergy, University of California, San Francisco, CA 94143-0711

Corresponding Author: mesangial{at}aol.com

Vasoactive intestinal peptide (VIP) and its G-protein coupled receptors, VPAC-1 and VPAC-2, are highly expressed in the immune system and modulate diverse T cell functions. The human VPAC-1 5' flanking region (1.4kb) contains 4 high-affinity Ikaros consensus sequences. Ikaros native protein from T cell nuclear extracts and IK-1 and IK-2 recombinant proteins recognized an IK high-affinity binding motif of the VPAC-1 promoter in electrophoretic mobility shift assays, by a sequence-specific mechanism, and anti-IK antibodies supershifted this complex. Stable NIH-3T3 clones overexpressing IK-1 or IK-2 isoforms were generated to investigate Ikaros regulation of endogenous VPAC-1 expression as assessed by quantifying VPAC-1 mRNA and protein. By traditional and fluorometric-based kinetic RT-PCR and 125I-VIP binding, both IK-1 and IK-2 suppressed endogenous VPAC-1 expression in NIH-3T3 clones by a range of 50-93%. When a series of nested deletions of the VPAC-1 luciferase reporter construct were transiently transfected into IK-2 clones there was up to a 41% decrease in transcriptional activity compared to vector control. Two major IK-2 binding domains also were identified at -1076 to –623bp and at –222 to –35bp, respectively. As both Ikaros and its novel target VPAC-1 are highly expressed in T cells, this system may be a dominant determinant of the VPAC-1 expression in immune responses. (Funded by NIH grant AI 29912 and a National Research Service Award F32DK10107-01).


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. Ronni, K. J. Payne, S. Ho, M. N. Bradley, G. Dorsam, and S. Dovat
Human Ikaros Function in Activated T Cells Is Regulated by Coordinated Expression of Its Largest Isoforms
J. Biol. Chem., January 26, 2007; 282(4): 2538 - 2547.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Harfi, S. D'Hondt, F. Corazza, and E. Sariban
Regulation of Human Polymorphonuclear Leukocytes Functions by the Neuropeptide Pituitary Adenylate Cyclase-Activating Polypeptide after Activation of MAPKs
J. Immunol., September 15, 2004; 173(6): 4154 - 4163.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
M. Delgado, D. Pozo, and D. Ganea
The Significance of Vasoactive Intestinal Peptide in Immunomodulation
Pharmacol. Rev., June 1, 2004; 56(2): 249 - 290.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. T. Dorsam, C. M. Ferrell, G. P. Dorsam, M. K. Derynck, U. Vijapurkar, D. Khodabakhsh, B. Pau, H. Bernstein, C. M. Haqq, C. Largman, et al.
The transcriptome of the leukemogenic homeoprotein HOXA9 in human hematopoietic cells
Blood, March 1, 2004; 103(5): 1676 - 1684.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Maccarrone, M. Bari, M. Di Rienzo, A. Finazzi-Agro, and A. Rossi
Progesterone Activates Fatty Acid Amide Hydrolase (FAAH) Promoter in Human T Lymphocytes through the Transcription Factor Ikaros: EVIDENCE FOR A SYNERGISTIC EFFECT OF LEPTIN
J. Biol. Chem., August 29, 2003; 278(35): 32726 - 32732.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
C Bauters, M-C Vantyghem, E Leteurtre, M-F Odou, C Mouton, N Porchet, J-L Wemeau, C Proye, and P Pigny
Hereditary phaeochromocytomas and paragangliomas: a study of five susceptibility genes
J. Med. Genet., June 1, 2003; 40(6): e75 - 75.
[Full Text] [PDF]


Home page
J. Immunol.Home page
K. J. Payne, G. Huang, E. Sahakian, J. Y. Zhu, N. S. Barteneva, L. W. Barsky, M. A. Payne, and G. M. Crooks
Ikaros Isoform X Is Selectively Expressed in Myeloid Differentiation
J. Immunol., March 15, 2003; 170(6): 3091 - 3098.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Dumortier, P. Kirstetter, P. Kastner, and S. Chan
Ikaros regulates neutrophil differentiation
Blood, March 15, 2003; 101(6): 2219 - 2226.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.